PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule | Ligand Name | Ligand Feature | Target Source | Glycan Sequence | Binding | PubMed ID ▼ |
---|---|---|---|---|---|---|---|
Unknown
|
Galactosylceramide (or derivative)
|
Monoglycosylceramides
|
Human colon epithelial HT29 cells
|
Gal(b1-1)Cer
|
Binding
|
||
Unknown
|
ICAM-1 (intercellular adhesion molecule-1) domain1/2
|
Glycoproteins
|
Primary chicken embryo fibroblasts (CEFs)
|
Binding
|
|||
Unknown
|
MHVR (murine member of the carcinoembryonic antigen family of glycoproteins)
|
Glycoproteins
|
BHK-21 cells
|
Binding
|
|||
Unknown
|
unnamed ligand
|
Oligosaccharides
|
Chinchilla tubotympanum
|
Gal(b1-4)GlcNAc(b1-3)Gal(b
|
Binding
|
||
PrsG (class III) G adhesins
|
Gb5 (Forssman glycolipid)
|
Oligoglycosylceramides
|
Acute cystitis patients
|
GalNAc(a1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
P-fimbriae
|
Gb5 (Forssman glycolipid)
|
Oligoglycosylceramides
|
Acute cystitis patients
|
GalNAc(a1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
PapG (class II) G adhesins
|
Gal alpha 1-4 Gal-containing isoreceptors
|
Glycosphingolipids
|
Patient with septic infection or pyelonephritis
|
Gal(a1-4)Gal
|
Binding
|
||
P-fimbriae
|
Gal alpha 1-4 Gal-containing isoreceptors
|
Glycosphingolipids
|
Patient with septic infection or pyelonephritis
|
Gal(a1-4)Gal
|
Binding
|
||
P-fimbriae
|
Gal alpha 1-4 Gal-containing isoreceptors
|
Glycosphingolipids
|
Pyelonephritis patients
|
Gal(a1-4)Gal
|
Binding
|
||
PapG (class I) G adhesins
|
Gal alpha 1-4 Gal-containing isoreceptors
|
Glycosphingolipids
|
Pyelonephritis patients
|
Gal(a1-4)Gal
|
Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01